ClinicalTrials.gg
Drug

Givosiran clinical trials

Also written GIVLAARI and ALN-AS1.

studies test it
4
open now
0
in phase 3
1
first study started
2015

How each study uses givosiran is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
20 Nov 2019 · GIVLAARI · NDA 212194 (FDA, Drugs@FDA)
European Union
2 Mar 2020 · Givlaari · EMEA/H/C/004775 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Givosiran
3

Brand

GIVLAARI
2

Development codes

ALN-AS1
2

Studies by the year they started

4 studies that test it; most in 2015 (1)

Studies that test givosiran, by start year
YearStudies
20151
20161
20171
20181

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
1
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 0

Alnylam Pharmaceuticals (4)

Studies

Open first, then newest update. How each study uses givosiran is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4

Codes

What other systems call givosiran · ClinicalTrials.gg INT001060

  • MeSH (NLM) C000630124givosiranOne source NLM
  • UNII (FDA) ROV204583WGIVOSIRANConfirmed FDA, NLM, Wikidata
  • RxNorm 2265712Confirmed FDA, Wikidata
  • Wikidata Q56297041givosiranConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C146805GivosiranOne source FDA
  • DrugBank DB15066One source Wikidata

Also registered as givosiran sodium (UNII 5XE21E41RT · RxNorm 2265859).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.